# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001125345-25-000047
Filing Date
2025-04-11
Accepted
2025-04-11 16:00:50
Documents
17
Period of Report
2025-05-21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | mgnx-20250411.htm iXBRL | DEF 14A | 983716
3 | SIGNATURE | mgnx-20250411_g1.jpg | GRAPHIC | 12731
4 | PVP CHART | mgnx-20250411_g2.jpg | GRAPHIC | 120485
5 | PROXY CARD PAGE 1 | mgnx-20250411_g3.jpg | GRAPHIC | 1345921
6 | PROXY CARD PAGE 2 | mgnx-20250411_g4.jpg | GRAPHIC | 551786
| Complete submission text file | 0001125345-25-000047.txt |  | 6160263

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | mgnx-20250411.xsd | EX-101.SCH | 922
19 | EXTRACTED XBRL INSTANCE DOCUMENT | mgnx-20250411_htm.xml | XML | 117379

Mailing Address 9704 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9704 MEDICAL CENTER DRIVE Rockville MD 20850 301-251-5172
MACROGENICS INC (Filer) CIK: 0001125345 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36112 | Film No.: 25831494
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)